ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: C-type lectin domain family 13 member D; C-type lectin domain family 13 member D-like; CD206; Human mannose receptor; MMR; Macrophage mannose receptor 1; Macrophage mannose receptor 1-like protein 1; hMR
Storage: 2-8C
Application: Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected MRC1 in Human lymph node tissue lysate.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected MRC1 in human lung tissue sections.Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected MRC1 in RAW 264.7 cells.Flow Cytometry Analysis: 0.01 mug from a representative lot detected MRC1 in RAW 264.7 cells.Affinity Binding Assay: A representative lot of this antibody bound MRC1 peptide with a KD of 4.6 x 10-8 in an affinity binding assay.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany